What is Citius Oncology, Inc.'s market capitalization?

Citius Oncology, Inc. (CTOR) reported market capitalization of $54.72M in Q1 2026.

How has Citius Oncology, Inc.'s market capitalization changed year-over-year?

Citius Oncology, Inc.'s market capitalization decreased by 17.8% year-over-year, from $66.54M to $54.72M.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Citius Oncology, Inc. CTOR Market capitalization

Market capitalization at other companies

Merck & Co.MRK

$297.4B+31.2%

Delcath SystemsDCTH

$322.44M-24.2%

Iovance Biotherapeutics, Inc.IOVA

$1.45B+32.4%

Cullinan Therapeutics, Inc.CGEM

$860.08M+94.2%

ImmunomeIMNM

$2.47B+323%

Arcus BiosciencesRCUS

$2.71B+226%

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Computed from the period-end share price: $54.72M.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s market capitalization?: Citius Oncology, Inc. (CTOR) reported market capitalization of $54.72M in Q1 2026.
How has Citius Oncology, Inc.'s market capitalization changed year-over-year?: Citius Oncology, Inc.'s market capitalization decreased by 17.8% year-over-year, from $66.54M to $54.72M.
What does market capitalization mean?: The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.